SEC 13F Intelligence

Fayez Sarofim & Co / MRK

Fayez Sarofim & Co’s Merck & Co Inc Position

Does Fayez Sarofim & Co own Merck & Co Inc (MRK)? Yes — 1.70M shares worth $205M (+0.52% of its 13F portfolio) as of Q1 2026, down from 1.74M shares the prior filed quarter.

Position Value
$205M
Q1 2026
Shares
1.70M
% of Portfolio
+0.52%
Quarters Held
30
currently held

Position History MRK

Reported value by quarter
Q4 ’18: $227MQ4 ’18Q1 ’19: $249MQ2 ’19: $258MQ3 ’19: $261MQ4 ’19: $285MQ4 ’19Q1 ’20: $249MQ2 ’20: $251MQ3 ’20: $271MQ4 ’20: $272MQ4 ’20Q1 ’21: $264MQ2 ’21: $265MQ3 ’21: $256MQ4 ’21: $265MQ4 ’21Q1 ’22: $284MQ2 ’22: $316MQ3 ’22: $298MQ4 ’22: $381MQ4 ’22Q1 ’23: $351MQ2 ’23: $276MQ3 ’23: $254MQ4 ’23: $303MQ4 ’23Q1 ’24: $291MQ2 ’24: $362MQ3 ’24: $329MQ4 ’24: $319MQ4 ’24Q1 ’25: $262MQ2 ’25: $207MQ3 ’25: $202MQ4 ’25: $183MQ4 ’25Q1 ’26: $205Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.70M$205M+0.52%
Q4 20251.74M$183M+0.44%
Q3 20252.41M$202M+0.47%
Q2 20252.62M$207M+0.50%
Q1 20252.92M$262M+0.65%
Q4 20243.20M$319M+0.77%
Q3 20242.90M$329M+0.84%
Q2 20242.92M$362M+0.98%
Q1 20242.20M$291M+0.87%
Q4 20232.41M$303M+0.93%
Q3 20232.46M$254M+0.86%
Q2 20232.40M$276M+0.97%
Q1 20233.30M$351M+1.23%
Q4 20223.43M$381M+1.41%
Q3 20223.46M$298M+1.18%
Q2 20223.46M$316M+1.15%
Q1 20223.46M$284M+0.90%
Q4 20213.46M$265M+0.79%
Q3 20213.41M$256M+0.85%
Q2 20213.41M$265M+0.89%
Q1 20213.42M$264M+0.97%
Q4 20203.32M$272M+1.04%
Q3 20203.26M$271M+1.16%
Q2 20203.24M$251M+1.16%
Q1 20203.24M$249M+1.53%
Q4 20193.13M$285M+1.37%
Q3 20193.11M$261M+1.35%
Q2 20193.08M$258M+1.34%
Q1 20193.00M$249M+1.32%
Q4 20182.98M$227M+1.37%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Fayez Sarofim & Co’s full portfolio or all institutional holders of MRK.